Unregulated Growth of Thailand's Recreational Cannabis Industry and Regulatory Concerns

Regulations by 2FIRSTS.ai

Nov.23.2023

Unregulated Growth of Thailand's Recreational Cannabis Industry and Regulatory Concerns

Thailand's unregulated recreational cannabis industry sees uncertain future as government drafts regulations. Debates arise on medical use restrictions.

According to a report by Infobae, the leisure marijuana industry in Thailand is experiencing unregulated growth. The government is currently drafting regulations to address this issue, but remains skeptical about permitting its use for medical marijuana purposes.

In addition, the Asia International Cannabis Expo and Forum kicked off today in Bangkok. Several experts are questioning whether the ban on recreational marijuana is beneficial for the growing cannabis industry.

Since the lifting of the ban on the cultivation and sale of marijuana by the government on June 9, 2023, over 8,000 recreational marijuana distribution stores have opened nationwide, making Thailand the first country in Asia to legalize marijuana. The current Prime Minister, Srettha Thavisin, had previously pledged to restrict marijuana to medicinal use only, but his alliance includes the Bhumjaithai party, which played a significant role in the legalization push last year.

While the future of recreational marijuana remains uncertain, the Ministry of Health has announced that this month it will propose a draft bill to regulate the industry.

References:

[1] El sector del cannabis crece sin control en Tailandia a la espera de su regularización

Also Read:

[1] Unregulated Growth of Thailand's Recreational Cannabis Industry and Regulatory Concerns

[2] Vietnam Government Seeks Public Opinion on Revised Export and Import Tax Regulations

[3] Call for Immediate Regulation of E-cigarettes and E-liquid in Malaysia

#Thailand #E-cigarette Industry #Cannabis vaporization #Cannabis e-cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

PMI Launches IQOS ILUMA i in the Philippines, Debuts via Official Stores and Online Channels

PMFTC, the Philippine affiliate of Philip Morris International (PMI), has introduced the heated tobacco device IQOS ILUMA i in the Philippines, featuring induction-heating technology and multiple smart functions. PMI aims to increase the share of smoke-free products to around 66% of its net revenues by 2030. Previously, PMFTC had already launched ZYN nicotine pouch products in Manila.

Nov.25 by 2FIRSTS.ai

Altria CEO Billy Gifford to Retire; Sal Mancuso Named Successor

Altria Group, Inc. (NYSE: MO) announced that CEO Billy Gifford will retire at the conclusion of the 2026 Annual Meeting of Shareholders on May 14, 2026, after more than 30 years with the company. The Board of Directors has elected Salvatore (Sal) Mancuso, Altria’s current Executive Vice President and CFO, to succeed him as CEO.

Dec.12 by 2FIRSTS.ai

Bangkok Police Bust Illegal E-Cigarette Warehouse, Seize Vapes Worth Over $112,000

Thai police raided an illegal e-cigarette warehouse, arrested a man accused of selling vapes online, and seized a large quantity of improperly imported products worth more than 4 million baht (about $112,000).